AZTA
Azenta, Inc.
AZTA lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
AZTA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Strong |
AZTA's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
AZTA PE Valuation
AZTA has no meaningful PE right now: it lost money over the past year.
AZTA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect AZTA's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
AZTA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.47 | — |
| Q2 2026 | -$2.67 | -$0.13 |
| Q1 2026 | -$3.87 | -$2.36 |
| Q4 2025 | -$1.26 | +$1.84 |
| Q3 2025 | -$1.21 | +$1.88 |
| Q2 2025 | -$2.54 | +$0.31 |
| Q1 2025 | -$1.51 | +$1.24 |
| Q4 2024 | -$3.10 | -$2.75 |
| Q3 2024 | -$3.09 | -$2.87 |
AZTA lost $2.67 per share over the past year, about the same as its loss the year before.
AZTA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $161.2M | +12% |
| Q1 2026 | $144.8M | +1% |
| Q4 2025 | $148.6M | +0.8% |
| Q3 2025 | $159.2M | -6.4% |
| Q2 2025 | $143.9M | -17% |
| Q1 2025 | $143.4M | -9.9% |
| Q4 2024 | $147.5M | -4.4% |
| Q3 2024 | $170.1M | -1.3% |
AZTA's revenue is recovering but still below its 2021 peak: $161M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.6% | -2.1 points |
| Q1 2026 | -115% | -103 points |
| Q4 2025 | -4.9% | +2.8 points |
| Q3 2025 | 1.2% | +8.4 points |
| Q2 2025 | -0.5% | +8 points |
| Q1 2025 | -11% | +81 points |
| Q4 2024 | -7.7% | +9.6 points |
| Q3 2024 | -7.2% | +2.4 points |
AZTA's operating margin was −2.6% last quarter, down 2.1 points from the same quarter a year ago.
AZTA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.2M | -135% |
| Q1 2026 | $6.1M | -13% |
| Q4 2025 | $14.7M | -34% |
| Q3 2025 | -$5.7M | -165% |
| Q2 2025 | $15M | +$19.8M |
| Q1 2025 | $7M | +357% |
| Q4 2024 | $22M | +52% |
| Q3 2024 | $8.8M | -71% |
AZTA usually generates cash, though not every quarter: the latest was −$5M, but it generated $10M over the past year.
AZTA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -9.7x | Net Cash |
| Q3 2025 | -8.0x | Net Cash |
| Q2 2025 | -9.0x | Net Cash |
| Q1 2025 | -10.6x | Net Cash |
| Q4 2023 | -46.4x | Net Cash |
| Q3 2023 | -54.5x | Net Cash |
| Q2 2023 | -101.8x | Net Cash |
| Q1 2023 | -70.5x | Net Cash |
AZTA has more cash than debt.
AZTA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.0 | Neutral |
| Stochastic | 64.2 | Neutral |
AZTA's weekly RSI is 69 (neutral) and its Stochastic is 64 (neutral).
AZTA PE vs Healthcare Sector
| Metric | AZTA | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
AZTA has no meaningful PE right now: it lost money over the past year.
AZTA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.9 | 16% above |
| 20 week MA | $33.4 | 31% above |
| 50 week MA | $29.8 | 47% above |
| 100 week MA | $32.5 | 35% above |
| 200 week MA | $42.0 | 4.5% above |
AZTA has climbed back above all five of its weekly moving averages, and it's now 4.5% above its 200-week average.
AZTA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.1 | $74.6 | +77% |
| 2021 | $74.6 | $101.0 | +35% |
| 2022 | $101.0 | $58.5 | -42% |
| 2023 | $58.5 | $65.1 | +11% |
| 2024 | $65.1 | $51.3 | -21% |
| 2025 | $51.3 | $34.8 | -32% |
| 2026 YTD | $34.8 | $43.9 | +26% |
AZTA has finished lower in three of the last six years. It's up 26% so far in 2026.